YS Biopharma Highlights Interim Results Of Pivotal Phase 3 Clinical Study Of PIKA Rabies Vaccine; Says Results Indicate That The Pika Rabies Vaccine Has Successfully Met The Primary Endpoints Of The Trial
YS Biopharma强调了PIKA狂犬病疫苗的关键性3期临床研究的中期结果；称结果表明皮卡狂犬病疫苗已成功达到试验的主要终点